TFIIS inhibitors constitute a class of chemical compounds that primarily target the transcriptional machinery within cells. Transcription, the first step of gene expression, involves the synthesis of RNA from a DNA template and plays a pivotal role in regulating various cellular processes. TFIIS (Transcription Factor II S) is a critical transcription factor involved in this process, facilitating RNA polymerase II-mediated elongation of RNA transcripts. The inhibitors within this class are designed to disrupt the function of TFIIS, consequently impeding RNA synthesis and transcriptional activity.
The mechanisms of action of TFIIS inhibitors can vary, but they predominantly focus on interfering with the catalytic activity of RNA polymerase II. One approach involves directly binding to RNA polymerase II or its associated factors, thereby inhibiting its ability to efficiently transcribe RNA. These inhibitors can also disrupt the TFIIS-TFIIB interaction, essential for proper transcription initiation and elongation. Additionally, some TFIIS inhibitors may target specific domains of TFIIS itself, preventing its binding to RNA polymerase II and subsequent RNA transcript elongation. By perturbing these key interactions, TFIIS inhibitors effectively impair the transcriptional process, ultimately leading to reduced RNA synthesis within cells. Researchers employ these compounds in molecular biology studies to gain insights into gene regulation, transcriptional control, and cellular responses to environmental cues. Understanding the mechanisms of TFIIS inhibitors sheds light on the intricate processes governing gene expression, offering valuable knowledge for various fields, including molecular biology, genetics, and cell biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Inhibits RNA polymerase II, blocking RNA synthesis. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Interferes with RNA synthesis by binding to DNA. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Blocks bacterial RNA polymerase, halting transcription. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
Inhibits CDK7, preventing RNA polymerase II phosphorylation. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Disrupts the TFIIH complex, affecting transcription initiation. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Inhibits CDK9, preventing RNA polymerase II elongation. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Topoisomerase I inhibitor, causing DNA cleavage during transcription. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Forms DNA adducts, hindering transcription and replication. | ||||||